Literature DB >> 11331782

Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.

D Zhang1, P J Beresford, A H Greenberg, J Lieberman.   

Abstract

Cytotoxic T lymphocytes (CTL) induce apoptosis by engaging death receptors or by exocytosis of cytolytic granules containing granzyme (Gzm) proteases and perforin. The lamins, which maintain the structural integrity of the nuclear envelope, are cleaved by caspases during caspase-mediated apoptosis. Although death receptor engagement and GzmB activate caspases, CTL also induce apoptosis during caspase blockade. Both GzmA and GzmB directly and efficiently cleave laminB in vitro, in situ in isolated nuclei and in cells loaded with perforin and Gzms, even in the presence of caspase inhibitors. LaminB is cleaved by GzmA at concentrations of 3 nM, but GzmB is 50 times less active. GzmA cuts laminB at R392; GzmB cuts at the caspase VEVD231 site. Characteristic laminB fragments generated by Gzm proteolysis also are observed during CTL lysis, even in the presence of caspase inhibitors or in cells overexpressing bcl-2. Lamins A/C are direct substrates of GzmA, but not GzmB. GzmA and GzmB therefore directly target critical caspase substrates in caspase-resistant cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331782      PMCID: PMC33284          DOI: 10.1073/pnas.101329598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid.

Authors:  M Barry; J A Heibein; M J Pinkoski; S F Lee; R W Moyer; D R Green; R C Bleackley
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.

Authors:  S H Kaufmann
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

3.  Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.

Authors:  F D McKeon; M W Kirschner; D Caput
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

Review 4.  The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes.

Authors:  R C Bleackley; C G Lobe; B Duggan; N Ehrman; C Fregeau; M Meier; M Letellier; C Havele; J Shaw; V Paetkau
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

5.  Granzyme A initiates an alternative pathway for granule-mediated apoptosis.

Authors:  S Shresta; T A Graubert; D A Thomas; S Z Raptis; T J Ley
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

6.  Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.

Authors:  S S Metkar; M Anand; P P Manna; K N Naresh; J J Nadkarni
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

7.  DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis.

Authors:  D A Thomas; C Du; M Xu; X Wang; T J Ley
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

8.  Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A.

Authors:  D Zhang; M S Pasternack; P J Beresford; L Wagner; A H Greenberg; J Lieberman
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

9.  A novel serine esterase expressed by cytotoxic T lymphocytes.

Authors:  M S Pasternack; H N Eisen
Journal:  Nature       Date:  1985 Apr 25-May 1       Impact factor: 49.962

Review 10.  Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.

Authors:  D E Jenne; J Tschopp
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

View more
  37 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 4.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 5.  Nuclear lamins and oxidative stress in cell proliferation and longevity.

Authors:  Takeshi Shimi; Robert D Goldman
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.

Authors:  Zusen Fan; Paul J Beresford; Dong Zhang; Judy Lieberman
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy.

Authors:  Lillian Sun; Ellen Moore; Rose Berman; Paul E Clavijo; Anthony Saleh; Zhong Chen; Carter Van Waes; John Davies; Jay Friedman; Clint T Allen
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

Review 8.  Granzyme B cleavage of autoantigens in autoimmunity.

Authors:  E Darrah; A Rosen
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

9.  A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.

Authors:  Felipe Andrade; Livia A Casciola-Rosen; Antony Rosen
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 10.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.